← Back to Clinical Trials
Recruiting NCT07336264

NCT07336264 Characterization of Acute Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07336264
Status Recruiting
Phase
Sponsor Children's National Research Institute
Condition Acute Pain, Postoperative
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-12-02
Primary Completion 2027-12-02

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 21 Years
Study Type OBSERVATIONAL
Interventions
AlgometRx Nociometer

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-12-02 with a primary completion date of 2027-12-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to better understand how acute pain and responses to pain treatment can be measured in children and adolescents using a non-invasive device. Pain is usually assessed using self-reported or observational scales, which can be difficult to interpret, especially in pediatric patients. This study will evaluate whether a novel device, the AlgometRx Nociometer, can provide an objective measure of nociceptive pain. Participants ages 6 to 21 years who are undergoing elective surgery or bone marrow transplantation will be enrolled at Children's National Hospital. The device measures changes in pupil size in response to gentle electrical stimulation, which reflects activity in pain-related nerve pathways. Measurements will be taken before and after procedures and during routine hospital care, alongside standard pain assessments. This is an observational study. Participation will not change or guide any medical treatment, and all pain management will follow standard clinical care. The information collected may help improve future pain assessment and treatment for pediatric patients.

Eligibility Criteria

Inclusion Criteria: * Children and adolescents ages 6 to 21 years * Undergoing elective surgical procedures without a history of chronic pain, OR undergoing or planning to undergo bone marrow transplantation (BMT) * Able to provide written informed assent and parental permission/consent, as applicable Exclusion Criteria: * Documented history of eye disease that precludes pupillometry * Unwilling or unable to participate

Contact & Investigator

Central Contact

Julia Finkel, M.D

✉ JFINKEL@childrensnational.org

📞 202-841-0362

Frequently Asked Questions

Who can join the NCT07336264 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 21 Years, studying Acute Pain, Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07336264 currently recruiting?

Yes, NCT07336264 is actively recruiting participants. Contact the research team at JFINKEL@childrensnational.org for enrollment information.

Where is the NCT07336264 trial being conducted?

This trial is being conducted at Washington D.C., United States.

Who is sponsoring the NCT07336264 clinical trial?

NCT07336264 is sponsored by Children's National Research Institute. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology